Standardized Timothy Grass Pollen Allergenic Extract: Phase I started

Greer began an open-label, dose-escalation, U.S. Phase I trial in 24 patients with Timothy grass pollen allergy and at least one systemic reaction to subcutaneous immunotherapy. ...